"Programmed polymeric devices" for pulsed drug delivery

Pharmaceutical Research

Volumn 21, Issue 10, 2004, Pages 1732-1740

  Stubbe, Barbara G ^a   De Smedt, Stefaan C ^a   Demeester, Joseph ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

drug delivery; pulsatile programmed drug delivery; pulsed drug release; vaccine delivery

Indexed keywords

2 HYDROXYETHYL METHACRYLATE; DEXTRAN; DRUG CARRIER; ENZYME; HORMONE; IMMUNOGLOBULIN G; LIPOSOME; METHYLPHENIDATE; MICROSPHERE; PLASMA PROTEIN; POLY(ORTHO ESTER); POLYANHYDRIDE; POLYGLACTIN; POLYLACTIC ACID; POLYMER; SALBUTAMOL SULFATE; TETANUS TOXOID; VIRUS ANTIGEN;

ANGINA PECTORIS; ASTHMA; BLOOD PRESSURE; CELL MEMBRANE PERMEABILITY; CIRCADIAN RHYTHM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG TOLERANCE; ENZYME BLOOD LEVEL; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; OSMOTIC PRESSURE; OSMOTIC PUMP; PARAMETER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSATILE DRUG RELEASE; REVIEW;

DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; ENZYMES; HYDROLYSIS; OSMOTIC PRESSURE; POLYMERS;

EID: 6344245651     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000045223.45400.01     Document Type: Review

References (61)

1. P. H. Redfern. The influence of biological rhytms on drug responses. Drug Del. Syst. Sci. 2:21-25 (2002).
2. J. Heller. Modulated release from drug delivery devices. Crit. Rev. Ther. Drug Carr. Syst. 10:253-305 (1993).
3. J. Kost. Pulsed and Self-Regulated Drug Delivery. CRC Press. Boca Raton, FL, 1990.
4. M. F. Powell. Drug Delivery issues in vaccine development. Pharm. Res. 13:1777-1785 (1996).
5. K. S. Soppimath, T. M. Aminabhavi, A. M. Dave, S. G. Kumbar, and W. E. Rudzinski. Stimulus-responsive "smart" hydrogels as novel drug delivery systems. Drug Dev. Ind. Pharm. 28:957-974 (2002).
6. S. Tanna, T. Sahota, J. Clark, and M. J. Taylor. A covalently stabilised glucose responsive gel formulation with a Carbopol carrier. J. Drug Target. 10:411-418 (2002).
7. G. P. Misra and R. A. Siegel. New mode of drug delivery: long term autonomous rhythmic hormone release across a hydrogel membrane. J. Control. Rel. 81:1-6 (2002).
8. K. Moriyama, T. Ooya, and N. Yui. Hyaluronic acid grafted with poly(ethylene glycol) as a novel peptide formulation. J. Control. Rel. 59:77-86 (1999).
9. N. Yui, T. Okano, and Y. Sakurai. Inflammation responsive degradation of crosslinked hyaluronic acid gels. J. Control. Rel. 22: 105-116 (1992).
10. N. Yui, J. Nihira, T. Okano, and Y. Sakurai. Regulated release of drug microspheres from inflammation responsive degradable matrices of crosslinked hyaluronic acid. J. Control. Rel. 25:133-143 (1993).
11. E. R. Edelman and R. Langer. Optimization of release from magnetically controlled polymeric drug release devices. Biomaterials 14:621-626 (1993).
12. A. Boucaud, M. A. Garrigue, L. Machet, L. Vaillant, and F. Patat. Effect of sonication parameters on transdermal delivery of insulin to hairless rats. J. Control. Rel. 81:113-119 (2002).
13. A. Tezel, A. Sens, J. Tuchscherer, and S. Mitragotri. Frequency dependence of sonophoresis. Pharm. Res. 18:1694-1700 (2001).
14. S. K. Li and A. D'Emanuele. On-off transport through a thermoresponsive hydrogel composite membrane. J. Control. Rel. 75: 55-67 (2001).
15. S. Kantaria, G. D. Rees, and M. J. Lawrence. Formulation of electrically conducting microemulsion-based organogels. Int. J. Pharm. 250:65-83 (2003).
16. A. V. Badkar and A. K. Banga. Electrically enhanced transdermal delivery of a macromolecule. J. Pharm. Pharmacol. 54:907-912 (2002).
17. P. F. Kiser, G. Wilson, and D. Needham. Lipid-coated microgels for triggered release of doxorubicin. J. Control. Rel. 68:9-22 (2000).
18. J. Kost and R. Langer. Responsive polymeric delivery systems. Adv. Drug Deliv. Rev. 46:125-148 (2001).
19. J. L. Cleland, M. F. Powell, A. Lim, L. Barron, P. W. Berman, D. J. Eastman, J. H. Nurnberg, T. Wrin, and J. C. Vennari. Development of a single-shot subunit vaccine for HIV-1. AIDS Res. Hum. Retroviruses 10(Suppl 2):S21-S66 (1994).
20. J. L. Cleland, L. Barron, P. W. Berman, A. Daugherty, T. Gregory, A. Lim, J. Vennari, T. Wrin, and M. F. Powell. Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response. J. Pharm. Sci. 85:1346-1349 (1996).
21. J. L. Cleland, L. Barron, A. Daugherty, D. Eastman, C. Kensil, A. Lim, R. P. Weissburg, T. Wrin, J. Vennari, and M. F. Powell. Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120. J. Pharm. Sci. 85:1350-1357 (1996).
22. J. L. Cleland, A. Lim, A. Daugherty, L. Barron, N. Desjardin, E. T. Duenas, D. J. Eastman, J. C. Vennari, T. Wrin, P. Berman, K. K. Murthy, and M. F. Powell. Development of a single-shot subunit vaccine for HIV-1. 5. Programmable in vivo autoboost and long lasting neutralizing response. J. Pharm. Sci. 87:1489-1495 (1998).
23. M. J. Alonso, S. Cohen, T. G. Park, R. K. Gupta. G. R. Siber, and R. Langer. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 10:945-953 (1993).
24. J. H. Eldridge, J. K. Staas, J. A. Meulbroek, J. R. McGhee, T. R. Tice, and R. M. Gilley. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 28:287-294 (1991).
25. Y. Men, B. Gander, H. P. Merkle, and G. Corradin. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. Vaccine 14:1442-1450 (1996).
26. C. Thomasin, G. Corradin, Y. Men, H. P. Merkle, and B. Gander. Tetanus toxoid and synthetic malaria antigen containing polylactide/poly(lactide-co- glycolide) microspheres: importance of polymer degradation and antigen release for immune response. J. Control. Rel. 41:131-145 (1996).
27. C. Thomasin, P. Johansen, R. Alder, R. Bemsel, and B. Gander. Contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation. Eur. J. Pharm. Biopharm. 42:16-24 (1996).
28. G. Zhu, S. R. Mallery, and S. P. Schwendeman. Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide). Nat. Biotechnol. 18:52-57 (2000).
29. G. Zhu and S. P. Schwendeman. Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives. Pharm. Res. 17:351-357 (2000).
30. T. Uchida, A. Yagi, Y. Oda, Y. Nakada, and S. Goto. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Chem. Pharm. Bull. 44:235-236 (1996).
31. A. Sanchez, R. K. Gupta, M. J. Alonso, G. R. Siber, and R. Langer. Pulsed controlled-released system for potential use in vaccine delivery. J. Pharm. Sci. 85:547-552 (1996).
32. S. M. Khoo and W. J. Thiel. 1994. Veterinary implants for delayed pulsed release of antigen. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 116-117. Proceedings of the International Symposium on Controlled Release of Bioactive Materials, Controlled Release Society, San Diego, Ca, 21, 116-117 (1994).
33. O. Franssen, L. Vandervennet, P. Roders, and W. E. Hennink. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. J. Control. Rel. 60:211-221 (1999).
34. R. J. Stenekes, A. E. Loebis, C. M. Fernandes, D. J. A. Crommelin, and W. E. Hennink. Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept. Pharm. Res. 17:690-695 (2000).
35. A. Kikuchi, M. Kawabuchi, A. Watanabe, M. Sugihara, Y. Sakurai, and T. Okano. Effect of Ca2+-alginate gel dissolution on release of dextran with different molecular weights. J. Control. Rel. 58:21-28 (1999).
36. A. Gopferich, D. Karydas, and R. Langer. Predicting drug release from cylindric polyanhydride matrix discs. Eur. J. Pharm. Biopharm. 41:81-87 (1995).
37. A. Gopferich. Bioerodible implants with programmable drug release. J. Control. Rel. 44:271-281 (1997).
38. P. Wuthrich, B. K. Fritzinger, K. V. Roskos, and J. Heller. Pulsatile and delayed release of lysozyme from ointment-like poly(orthoesters). J. Control. Rel. 21:191-200 (1992).
39. W. Vogelhuber, P. Rotunno, E. Magni, A. Gazzaniga, T. Spruss, G. Bernhardt, A. Buschauer, and A. Gopferich. Programmable biodegradable implants. J. Control. Rel. 73:75-88 (2001).
40. A. Gopferich. Mechanisms of polymer degradation and erosion. Biomaterials 17:103-114 (1996).
41. H. L. Jiang and K. J. Zhu. Pulsatile protein release from a laminated device comprising of polyanhydrides and pH-sensitive complexes. Int. J. Pharm. 194:51-60 (2000).
42. L. Y. Qiu and K. J. Zhu. Design of a core-shelled polymer cylinder for potential programmable drug delivery. Int. J. Pharm. 219:151-160 (2001).
43. O. Franssen, O. P. Vos, and W. E. Hennink. Delayed release of a model protein from enzymatically degrading dextran hydrogels. J. Control. Rel. 44:237-245 (1997).
44. O. Franssen, R. J. Stenekes, and W. E. Hennink. Controlled release of a model protein from enzymatically degrading dextran microspheres. J. Control. Rel. 59:219-228 (1999).
45. P. G. Kibat, Y. Igari, M. A. Wheatley, H. N. Eisen, and R. Langer. Enzymatically activated microencapsulated liposomes can provide pulsatile drug release. FASEB J. 4:2533-2539 (1990).
46. K. Moriyama, T. Ooya, and N. Yui. Pulsatile peptide release from multi-layered hydrogel formulations consisting of poly(ethylene glycol)-grafted and ungrafted dextrans. J. Biomater. Sci. Polym. Ed. 10:1251-1264 (1999).
47. G. Santus and R. W. Baker. Osmotic drug delivery: review of the patent literature. J. Control. Rel. 35:1-21 (1995).
48. A. Linkwitz, J. A. Magruder, and S. Merrill. Osmotically driven delivery device with expandable orifice for pulsatile delivery effect. U.S. Patent 5,221,278, 1993.
49. P. R. Magruder, B. Barclay, P. S. L. Wong, and F. Theeuwes. Composition comprising salbutamol. U.S. Patent 4,751,071, 1988.
50. C. Henry. Chemical and Engineering News. 78:49-65 (2000). Engineering a new drug delivery profile 2000. Chemical and Engineering News 18:57
51. C. Henry. Chemical and Engineering News. 78:49-65 (2000). Engineering a new drug delivery profile 2000. Chemical and Engineering News 18:57
52. J. S. Markowitz, A. B. Straughn, K. S. Patrick, C. L. DeVane, L. Pestreich, J. Lee, Y. Wang, and R. Muniz. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Clin. Pharmacokinet. 42: 393-401 (1903).
53. R. W. Baker. Controlled release delivery system by an osmotic bursting mechanism. U.S. Patent 3,952,741, 1975.
54. D. O. Kuethe, D. C. Augenstein, J. D. Gresser, and D. L. Wise. Design of capsules that burst at predetermined times by dialysis. J. Control. Rel. 18:159-164 (1992).
55. S. Ueda, T. Hata, S. Asakura, H. Yamaguchi, M. Kotani, and Y. Ueda. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design. J. Drug Target. 2:35-44 (1994).
56. W. J. Thiel, S. J. Wyatt, I. Barr, and M. Kleinig. In vitro and in vivo testing of a single dose vaccination system. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 21:841-842 (1994).
57. M. Cardamone, S. A. Lofthouse, J. C. Lucas, R. P. Lee, and M. R. Brandon. In vitro testing of pulsatile delivery system and its in vivo application for immunization against tetanus toxoid. J. Control. Rel. 47:205-219 (1997).
58. R. M. Iskakov, A. Kikuchi, and T. Okano. Time-programmed pulsatile release of dextran from calcium-alginate gel beads coated with carboxy-n-propylacrylamide copolymers. J. Control. Rel 80:57-68 (2002).
59. B. G. Stubbe, K. Braeckmans, F. Horkay, W. E. Hennink, S. C. De Smedt, and J. Demeester. Swelling pressure observations on degrading dex-HEMA hydrogels. Macromolecules 35:2501-2505 (2002).
60. B. G. Stubbe, F. Horkay, B. Amsden, W. E. Hennink. S. C. De Smedt, and J. Demeester. Tailoring the Swelling pressure of degrading dextran hydroxyethyl methacrylate hydrogels. Biomacromolecules 4:691-695 (2003).
61. S. Murata, S. Ueda, F. Shimojo, Y. Tokunaga, T. Hata, and N. Ohnishi. In vivo performance of time-controlled explosion system (TES) in GI physiology regulated dogs. Int. J. Pharm. 161: 161-168 (1998).